Rendu Biotechnology
IPOFocused on RNA detection technology innovation
Shanghai, China · Founded 2007
- Headquarters
- Shanghai
- Founded
- 2007
- Business Model
- B2B
- Website
- rdbio.com
- Last Round
- Venture RoundJun 2019
- Rounds
- 3
About
Shanghai Rendu Biotechnology Co., Ltd. (Sci Tech Innovation Edition, stock code: 688193) is a Chinese biotech company focused on RNA detection technology innovation. Founded in 2007 and headquartered in the Zhangjiang High-tech Park in Shanghai, the company has over 17 years of expertise in RNA diagnostics. Its products cover five major clinical areas: reproductive health, blood-borne infectious diseases, respiratory infections, enteroviruses, and tumor early screening. The company serves over 700 medical institutions and holds 97 domestic and foreign patents, including two world-first launched products.
Summary
Rendu Biotechnology is a Biotech company based in Shanghai, China, founded in 2007. Its most recent funding was a Venture Round round in Jun 2019. Investors include Qiming VP.
Funding History
Mar 2022
Sign up to see all 4 rounds
Series A through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rendu-biotechnology"><img src="https://indexed.vc/api/badge/company/rendu-biotechnology" alt="Rendu Biotechnology on Indexed.vc" width="260" height="76" /></a>